4,7-Dihydro-2-(4-morpholinylmethyl)-4-oxo-7-(2-pyridinyl)furo[2,3-b]pyridine-5-carboxylic acid ethyl ester | 562100-96-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 4,7-Dihydro-2-(4-morpholinylmethyl)-4-oxo-7-(2-pyridinyl)furo[2,3-b]pyridine-5-carboxylic acid ethyl ester
• 英文别名: ethyl 2-(morpholin-4-ylmethyl)-4-oxo-7-pyridin-2-ylfuro[2,3-b]pyridine-5-carboxylate
• CAS: 562100-96-3
• 化学式: C₂₀H₂₁N₃O₅
• 分子量: 383.404
• InChiKey: ZGHWOAASCVZYRC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  28
• 可旋转键数：
  6
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.35
• 拓扑面积：
  85.1
• 氢给体数：
  0
• 氢受体数：
  8

反应信息

• 作为反应物：
  描述：

  4,7-Dihydro-2-(4-morpholinylmethyl)-4-oxo-7-(2-pyridinyl)furo[2,3-b]pyridine-5-carboxylic acid ethyl ester 、 对氯苄胺 以 乙二醇 为溶剂， 生成 N-[(4-chlorophenyl)methyl]-2-(morpholin-4-ylmethyl)-4-oxo-7-pyridin-2-ylfuro[2,3-b]pyridine-5-carboxamide
  参考文献：
  名称：

  Synthesis of 4-oxo-4,7-dihydrofuro[2,3-b]pyridine-5-carboxamides with broad-spectrum human herpesvirus polymerase inhibition

  摘要：

  A versatile synthesis of 4-oxo-4,7-dihydrofuro[2,3-b]pyridine-5-carboxylate esters has been developed which has lead to the identification of a new series of non-nucleoside inhibitors of human herpesvirus polymerases HCMV, HSV-1, EBV, and VZV with high specificity compared to human DNA polymerases. (C) 2008 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2008.06.060
• 作为产物：
  描述：

  4,7-Dihydro-4-oxo-7-(2-pyridinyl)furo[2,3-b]pyridine-5-carboxylic acid ethyl ester 、 N-(methylene)morpholinium chloride 以 乙腈 为溶剂， 生成 4,7-Dihydro-2-(4-morpholinylmethyl)-4-oxo-7-(2-pyridinyl)furo[2,3-b]pyridine-5-carboxylic acid ethyl ester
  参考文献：
  名称：

  Synthesis of 4-oxo-4,7-dihydrofuro[2,3-b]pyridine-5-carboxamides with broad-spectrum human herpesvirus polymerase inhibition

  摘要：

  A versatile synthesis of 4-oxo-4,7-dihydrofuro[2,3-b]pyridine-5-carboxylate esters has been developed which has lead to the identification of a new series of non-nucleoside inhibitors of human herpesvirus polymerases HCMV, HSV-1, EBV, and VZV with high specificity compared to human DNA polymerases. (C) 2008 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2008.06.060

文献信息

• 4-OXO-4,7-DIHYDROFURO[2,3-B]PYRIDINE-5-CARBOXAMIDE ANTIVIRAL AGENTS
  申请人：——

  公开号：US20040259907A1

  公开（公告）日：2004-12-23

  The invention provides a compound of formula I: 1 wherein G, R 2 , R 3 , and R 4 have any of the values defined in the specification, or a pharmaceutically acceptable salt thereof, as well as processes and intermediates useful for preparing such compounds or salts, and methods of treating a herpesvirus infection using such compounds or salts.

  该发明提供了公式I的化合物：1其中G、R2、R3和R4具有规范中定义的任何值，或其药学上可接受的盐，以及用于制备这种化合物或盐的过程和中间体，以及使用这种化合物或盐治疗疱疹病毒感染的方法。
• 4-OXO-4,7-DIHYDROFURO(2,3-B)PYRIDINE-5-CARBOXAMIDE ANTIVIRAL AGENTS
  申请人：PHARMACIA & UPJOHN COMPANY

  公开号：EP1465895A2

  公开（公告）日：2004-10-13
• US6878705B2
  申请人：——

  公开号：US6878705B2

  公开（公告）日：2005-04-12
• [EN] 4-OXO-4, 7-DIHYDROFURO[2,3-b]PYRIDINE-5-CARBOXAMIDE ANTIVIRAL AGENTS<br/>[FR] AGENTS ANTIVIRAUX 4-OXO-4, 7-DIHYDROFURO[2,3-B]PYRIDINE-5-CARBOXAMIDE
  申请人：UPJOHN CO

  公开号：WO2003059911A2

  公开（公告）日：2003-07-24

  The invention provides a compound of formula I: (I) Wherein G, R2, R3, and R4 have any of the values defined in the specification, or a pharmaceutically acceptable salt thereof, as well as processes and intermediates useful for preparing such compounds or salts, and methods of treating a herpesvirus infection using such compounds or salts.